Budget Amount *help |
¥16,770,000 (Direct Cost: ¥12,900,000、Indirect Cost: ¥3,870,000)
Fiscal Year 2020: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2019: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2018: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
|
Outline of Final Research Achievements |
We found that the administration of anti-IgE antibody to pregnant mouse suppressed the production of antigen-specific IgE antibody in pups and thus prevent the development of food allergy. On the other hand, other immune responses such as antigen-specific T cell responses and IgG antibody production were not altered, which indicated the effect of anti-IgE antibody is IgE specific. Although the duration of the effect of anti-IgE antibody varied depending on the mouse strains, inhibition of IgE antibody production was observed in all strains. In addition, the administration of anti-IgE antibody during the neonatal period showed comparable effect with those in the pregnancy period. Taken together, the administration of anti-IgE antibody during pregnancy or neonatal period could be a promising strategy to prevent allergic diseases in children.
|